The US drug manufacturer of a treatment used by Aids patients has decided to go back on the 5,000% cost increase for the medicine.
Turing Pharmaceuticals has told US media that the company would go back on a 5,000% price increase on the drug Daraprim. Turing gained the rights to Daraprim – designed to fight parasitic infections – in August and subsequently raised the price of a tablet from $13.50 to $750. The controversial decision attracted widescale criticism, with one medical group…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
